Study: VEGF-A modified RNA helps convert cardiac cells into blood vessels

09/11/2013 | San Diego Union-Tribune

Researchers from Harvard University and Karolinska Institute in Stockholm converted cardiac stem cells into blood vessels using synthetic messenger RNA in the damaged hearts of mice. The study in Nature Biotechnology shows the potential of using modified RNA that codes for the protein VEGF-A in the development of new heart tissue. AstraZeneca and Moderna Therapeutics are working to develop the approach for use in patients.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC